Reward deficiency syndrome: genetic aspects of behavioral disorders

https://doi.org/10.1016/S0079-6123(00)26022-6Get rights and content

Abstract

The dopaminergic and opiodergic reward pathways of the brain are critical for survival since they provide the pleasure drives for eating, love and reproduction; these are called ‘natural rewards’ and involve the release of dopamine in the nucleus accumbens and frontal lobes. However, the same release of dopamine and production of sensations of pleasure can be produced by ‘unnatural rewards’ such as alcohol, cocaine, methamphetamine, heroin, nicotine, marijuana, and other drugs, and by compuslive activities such as gambling, eating, and sex, and by risk taking behaviors. Since only a minority of individuals become addicted to these compounds or behaviors, it is reasonable to ask what factors distinguish those who do become addicted from those who do not. It has usually been assumed that these behaviors are entirely voluntary and that environmental factors play the major role; however, since all of these behaviors have a significant genetic component, the presence of one or more variant genes presumably act as risk factors for these behaviors. Since the primary neurotransmitter of the reward pathway is dopamine, genes for dopamine synthesis, degradation, receptors, and transporters are reasonable candidates.

References (153)

  • R.D. Hunt et al.

    Clonidine benefits children with attention deficit disorder and hyperactivity: report of a double-blind placebo-crossover therapeutic trial

    J. Amer Acad. Child Psychiatry

    (1985)
  • E. Jönsson et al.

    Dopamine-related genes and their relationship to monoamine metabolites in CSF

    Biol. Psychiatry

    (1996)
  • G.F. Koob

    Drug of abuse: anatomy, pharmacology and function of reward pathways

    Trends Pharmacol. Sci.

    (1992)
  • M. Lepore et al.

    Conditioned place preference induced by Δ9-tetrahydrocannabinol: comparision with cocaine, morphine, and food reward

    Life Sci.

    (1995)
  • A.F. Arnsten et al.

    The contribution of α2-noradrenergic mechanism to prefrontal cortical cognitive function: potential significance for Attention-Deficit Hyperactivity Disorder

    Arch. Gen. Psychiatry

    (1996)
  • A.F.T. Amsten

    Catecholamine regulation of the prefrontal cortex

    J. Psychopharmacology

    (1997)
  • A.F.T. Amsten et al.

    Reversal of stress-induced delayed response deficits in rhesus monkeys by clonidine and naloxone

    Soc. Neurosci. Abstr.

    (1986)
  • V. Asghari et al.

    Modulation of interacellular cyclic AMP levels by different human dopamine D4 receptor variants

    J. Neurochem.

    (1995)
  • H. Begleiter et al.

    Event-related brain potentials in boys at risk for alcoholism

    Science

    (1984)
  • J. Benjamin et al.

    Dopamine D4 receptor gene association with normal personality traits

    Psychiat. Genet.

    (1995)
  • K. Blum et al.

    Increased prevalence of the Taq I A1 allele of the dopamine receptor gene (DRD(2)) in obesity with comorbid substance use disorder: a preliminary report

    Pharmacogenetics

    (1996)
  • K. Blum et al.

    Reward Deficiency Syndrome

    Am. Scientist

    (1996)
  • K. Blum et al.

    Allelic association of human dopamine D2 receptor gene in alcoholism

    J. Am. Med. Assn.

    (1990)
  • K. Blum et al.

    The D2 dopamine receptor gene as determinant of reward deficiency syndrome

    J.R. Soc. Med.

    (1996)
  • K. Blum et al.

    Dopamine D2 receptor gene variants: Association and linkage studies in impulsive, addictive and compulsive disorders

    Pharmacogenetics

    (1995)
  • M. Bond

    Defense style questionnaire

  • D.L. Braff et al.

    Impaired speed of visual information processing in marijuana intoxication

    Am. J. Psychiatry

    (1981)
  • C.L.E. Broekkamp et al.

    Stimulant effects of enkephalin microinjection into the dopaminergic A10 area

    Nature

    (1979)
  • H.G. Brunner et al.

    Abnormal behavior associated with a point mutation in the structural gene for monamine oxidase A

    Science

    (1993)
  • J.R. Bunzow et al.

    Cloning and expression of a rat D2 dopamine receptor cDNA

    Nature

    (1988)
  • R.J. Cadoret et al.

    Genetic and environmental factors in alcohol abuse and antisocial personality

    J. Stud. Alc.

    (1987)
  • R.J. Cadoret et al.

    Adoption study demostrating two genetic pathways to drug abuse

    Arch. Gen. Psychiatry

    (1995)
  • M. Caron

    A mouse knockout

    Am. J. Psychiatry

    (1996)
  • J. Chen et al.

    Δ9-tetrahydrocannabinol produces naloxone-blockable enhancement of presynaptic basal dopamine efflux in nucleus accumbens of conscious, freely-moving rats as measured by intracerebral microdialysis

    Psychopharmacology, (Berl.)

    (1990)
  • P.B.S. Clarke

    Mesolimbic dopamine activation - the key to nicotine reinforcement

  • C.R. Cloninger

    A systematic method for clinical description and classification of personality variants: a proposal

    Arch. Gen. Psychiatry

    (1987)
  • C.R. Cloninger et al.

    The Tridimensional Personality Questionnaire

    U.S. Normative data. Psychol. Rep.

    (1991)
  • C.R. Cloninger et al.

    Childhood personality predicts alcohol abuse in young adults

    Alc. Clin. Exp. Res.

    (1988)
  • C.R. Cloninger et al.

    Inheritance of risk to develop alcoholism

    Natl Inst. Drug. Abuse Res. Monogr. Ser.

    (1986)
  • C.R. Cloninger et al.

    A psychobiological model of temperament and character

    Arch. Gen. Psychiatry

    (1993)
  • D.E. Comings

    Tourette Syndrome and Human Behavior

    (1990)
  • D.E. Comings

    Polygenetic inheritance of psychiatric disorders

  • D.E. Comings

    Polygenic inheritance and micro/ minisatellites

    Mol. Psychiatry

    (1998)
  • D.E. Comings

    Letter to the editor: Tourette syndrome a polygenic disorder

    CNS Spectrums

    (1999)
  • D.E. Comings

    Molecular heterosis as the explanation for the controversy about the effect of the DRD2 gene on dopamine D2 receptor density

    Mol. Psychiatry

    (1999)
  • D.E. Comings

    SNPs and polygenic disorders: a less gloomy view

    Mol. Psychiatry

    (1999)
  • D.E. Comings et al.

    Comorbid behavioral disorders

  • D.E. Comings et al.

    The dopamine D2 receptor locus as a modifying gene in neuropsychiatric disorders

    J. Am. Med. Assn.

    (1991)
  • D.E. Comings et al.

    Association of the enkephalinase gene with low amplitude P300 waves

    NeuroReport

    (1999)
  • D.E. Comings et al.

    Additive effect of three noradrenergic genes (ADRA2A, ADRA2C, DBH) on attention deficit hyperactivity disorder and learning disabilities in Tourette syndrome subjects

    Clin. Genet.

    (1999)
  • Cited by (543)

    • A review of the genetic basis of problematic Internet use

      2022, Current Opinion in Behavioral Sciences
    View all citing articles on Scopus
    View full text